Zivo BioscienceZIVO
13F holders, Q4 2025 (December 31)3holders +1
1new positions
0sold out
$8.70avg. 13F price*
At the end of Q4 2025, 3 institutions reported holding Zivo Bioscience Inc. (ZIVO) in their 13F filings, up 1 from Q3 2025. 1 opened new positions and 0 sold out. The largest holders were CoreCap Advisors, LLC ($38K), Kohmann Bosshard Financial Services, LLC ($4K) and Huntington National Bank ($905).
- Company
- Zivo Bioscience Inc.
- CUSIP
- 98978N309
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $4K |
| Exits | 0 | $0 |
All 13F filers, Q3 2025 → Q4 2025: 500 shares bought, net +500 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| CoreCap Advisors, LLC | 0.00% | No change | 4,360 | $38K |
| Kohmann Bosshard Financial Services, LLC | 0.00% | New | 500 | $4K |
| Huntington National Bank | 0.00% | No change | 104 | $905 |
"% of holder's portfolio" is ZIVO's weight in each manager's 13F, not the share of Zivo Bioscience Inc. the manager owns.